Gilead Science

Gilead Earnings Preview: Non-Sovaldi Sales Bogey Of $2.94B May Be Unrealistic
Seeking Alpha
Wed, 07/23/14 - 09:17 am
earnings
Sovaldi
Gilead Science
Gilead Wins FDA Approval for Blockbuster Hepatitis C Pill
Bloomberg
Fri, 12/6/13 - 05:41 pm
sofosbuvir
FDA
Gilead Science
hepatitis C
Sovaldi